¹Î°æÈÆ

  • Áø·á°ú

    È£Èí±â¡¤¾Ë·¹¸£±â³»°ú

  • Àü¹®Áø·áºÐ¾ß

    ¸¸¼ºÆó¼â¼ºÆóÁúȯ, õ½Ä, ±â°üÁöÈ®ÀåÁõ, ±âŸ±âµµÁúȯ, ¸¸¼º±âħ

  • ´ã´çŬ¸®´Ð

¹Î°æÈÆ

¹Î°æÈÆ ±³¼öÀÇ Áø·á½Ã°£Ç¥ Áø·á¿¹¾à

Áø·á°ú/¼¾ÅÍ ¿ù È­ ¼ö ¸ñ ±Ý Åä Àü¹®Áø·á°ú¸ñ
È£Èí±â¡¤¾Ë·¹¸£±â³»°ú -
Á¾ÀÏ
-
Á¾ÀÏ
- - ¸¸¼ºÆó¼â¼ºÆóÁúȯ, õ½Ä, ±â°üÁöÈ®ÀåÁõ, ±âŸ±âµµÁúȯ, ¸¸¼º±âħ

¹Î°æÈÆ ±³¼öÀÇ »ó¼¼Á¤º¸

ÇзÂ

more
  • 1994 .03  ~  2000 .02  :  ÀüºÏ´ëÇб³ ÀÇÇаú
  • 2002 .03  ~  2004 .02  :  ÀüºÏ´ëÇб³ ÀϹݴëÇпø ÀÇÇаú ³»°úÇÐ(È£Èí±âÇÐ) ¼®»ç
  • 2004 .03  ~  2006 .02  :  ÀüºÏ´ëÇб³ ÀϹݴëÇпø ÀÇÇаú ³»°úÇÐ(È£Èí±âÇÐ) ¹Ú»ç

°æ·Â

more
  • 2000  ~  2001  :  ÀüºÏ´ëÇб³º´¿ø ÀÎÅÏ
  • 2001  ~  2005  :  ÀüºÏ´ëÇб³º´¿ø ³»°ú Àü°øÀÇ
  • 2005  ~  2007  :  ÀüºÏ´ëÇб³º´¿ø È£Èí±â¡¤¾Ë·¹¸£±â³»°ú ÀüÀÓÀÇ
  • 2007  ~  2010  :  ±¹±º¼öµµº´¿ø È£Èí±â³»°ú ±ºÀÇ°ü
  • 2008  ~  2009  :  ±¹±º¼öµµº´¿ø È£Èí±â³»°ú °úÀå
  • 2008  ~  2009  :  ±¹±º¼öµµº´¿ø °¨¿°°ü¸®À§¿øȸ ½Ç¹«ÆÀÀå
  • 2008  ~  2010  :  ±¹±º¼öµµº´¿ø ±¹°¡¹æ»ç¼±ºñ»óÁø·áÆÀ ÆÀ¿ø
  • 2010  ~  2011  :  ÀüºÏ´ëÇб³º´¿ø È£Èí±â¡¤¾Ë·¹¸£±â³»°ú ÀÓ»óÁ¶±³¼ö
  • 2011  ~   :  °í·Á´ëÇб³ ±¸·Îº´¿ø È£Èí±â³»°ú ÀÓ»óÁ¶±³¼ö
  • 2011  ~   :  ±¹°¡°áÇÙ°ü¸® ¹Î°£•°ø°øÇù·Â»ç¾÷ °í·Á´ëÇб³ ±¸·Îº´¿ø Ã¥ÀÓÀÚ
  • 2011  ~  2013  :  ±¹°¡°áÇÙ°ü¸® ¹Î°£•°ø°øÇù·Â»ç¾÷ ¼­¿ï¼­³²±Ç¿ª °£»ç
  • 2012  ~   :  Tuberculosis and Respiratory Diseases¡¯ Invited Reviewer
  • 2013  ~  2016  :  °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç Á¶±³¼ö / °í·Á´ëÇб³ ±¸·Îº´¿ø È£Èí±â³»°ú Á¶±³¼ö
  • 2013  ~   :  Áúº´°ü¸®º»ºÎ Çмú/Á¤Ã¥¿ë¿ª»ç¾÷ Æò°¡À§¿ø
  • 2014  ~  2015  :  °í·Á´ëÇб³ ±¸·Îº´¿ø ÁßȯÀÚ½Ç ¿î¿µÀ§¿øȸ À§¿ø
  • 2014  ~   :  The Clinical Respiratory Journal Invited Reviewer
  • 2014  ~   :  Respirology¡¯ Invited Reviewer
  • 2016  ~   :  Áúº´°ü¸®º»ºÎ È£Èí±â °¨¿°º´ ÀÚ¹®À§¿ø
  • 2016  ~  2019  :  °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç ºÎ±³¼ö / °í·Á´ëÇб³ ±¸·Îº´¿ø È£Èí±â³»°ú ºÎ±³¼ö
  • 2016  ~  2019  :  Áúº´°ü¸®º»ºÎ º´¿ø±â¹ÝÇü È£Èí±â°¨¿°º´°¨½Ãü°è¿î¿µ»ç¾÷ Á߾ӿÀ§¿øȸ À§¿ø
  • 2017  ~   :  Çѱ¹ÀÇ·áºÐÀïÁ¶Á¤ÁßÀç¿ø ÀÇ·á»ç°í°¨Á¤´Ü ºñ»óÀÓ °¨Á¤À§¿ø
  • 2017  ~  2019  :  ÀÇ·á±â°üÆò°¡ÀÎÁõ¿ø ȯÀÚ¾ÈÀü ÀÚ¹®À§¿ø
  • 2017  ~  2019  :  Áúº´°ü¸®º»ºÎ ÀÎÇ÷翣ÀÚºÐ¾ß Àü¹®°¡ ÀÚ¹®À§¿ø´Ü À§¿ø
  • 2017  ~   :  ¡®American Journal of Respiratory and Critical Care Medicine¡¯ Invited Reviewer
  • 2017  ~   :  °í·Á´ëÇб³ ±¸·Îº´¿ø ÀÓÁ¾°úÁ¤ ÆÇ´Ü ¹× ¿¬¸íÀÇ·á°áÁ¤ Àü¹®ÀÇ
  • 2017  ~   :  ¡®BMJ Case Reports¡¯ Invited Reviewer
  • 2018 .01  ~   :  Invited Reviewer: ¡®HIV/AIDS - Research and Palliative Care¡¯
  • 2018  ~   :  °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ÀÇÇаú Áø·á¼öÇà°ú¼ú±â ¸ðµâ ´ëÇ¥±³¼ö
  • 2018  ~   :  Invited Reviewer: ¡®Journal of International Medical Research¡¯
  • 2018  ~   :  Invited Reviewer: ¡®Infection and Drug Resistance¡¯
  • 2019  ~   :  Invited Reviewer: ¡®International Journal of Chronic Obstructive Pulmonary Disease¡¯
  • 2019  ~   :  ±¹¹Î°Ç°­º¸Çè°ø´Ü Àü¹®°¡ ÀÚ¹®À§¿ø
  • 2019  ~   :  °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç ±³¼ö / °í·Á´ëÇб³ ±¸·Îº´¿ø È£Èí±â³»°ú ±³¼ö
  • 2019  ~   :  Invited Reviewer: ¡®Journal of Thoracic Disease¡¯
  • 2020  ~   :  º¸°Çº¹ÁöºÎ ¼ö·Ãȯ°æÆò°¡À§¿øȸ 2020³âµµ ¼ö·Ãȯ°æÆò°¡ Æò°¡À§¿ø

¼ö»ó³»¿ª

more
  • 2008 .11  :  º¸°Çº¹Áö°¡Á·ºÎ 2008³â AI ÀÎü°¨¿° ¿¹¹æ»ç¾÷ À¯°ø ǥâÀå
  • 2010 .10  :  MARQUIS Who¡¯s Who in the World 2011 Àθí»çÀü µîÀç
  • 2019 .03  :  °í·Á´ëÇб³ ±¸·Îº´¿ø BEST ȸ½ÅÀÇ·áÁø
  • 2020 .03  :  °í·Á´ëÇб³ ±¸·Îº´¿ø BEST ȸ½ÅÀÇ·áÁø

ÇÐȸȰµ¿

more
  • 2011 .07  ~   :  ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ ±¹°¡°áÇÙ°ü¸® ¹Î°£¡¤°ø°øÇù·Â»ç¾÷ °í·Á´ëÇб³ ±¸·Îº´¿ø Ã¥ÀÓÀÚ
  • 2011 .07  ~   :  ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ ±¹°¡°áÇÙ°ü¸® ¹Î°£¡¤°ø°øÇù·Â»ç¾÷ ¼­¿ï¼­³²±Ç¿ª °£»ç
  • 2012 .01  ~   :  ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ 'Tuberculosis and Respiratory Diseases' ½É»çÀ§¿ø(Reviewer)
  • 2005 .03  ~   :  ´ëÇѳ»°úÇÐȸ
  • 2006 .07  ~   :  American Thoracic Society
  • 2009 .09  ~   :  ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ
  • 2009 .09  ~   :  ´ëÇÑõ½Ä¹×¾Ë·¹¸£±âÇÐȸ
  • 2009 .09  ~   :  ´ëÇÑÆó¾ÏÇÐȸ
  • 2012 .03  ~   :  European Respiratory Society
  • 2014 .01  ~  2014 .10  :  2014 ¸¸¼ºÆó¼â¼ºÆóÁúȯ ÀÓ»óÁø·áÁöħ ÇмúÀ§¿ø
  • 2014 .01  ~  2014 .10  :  2014 õ½Ä ÀÓ»óÁø·áÁöħ ¿î¿µÀ§¿ø ¹× ÇмúÀ§¿ø
  • 2014 .04  ~   :  World Association for Bronchoscopy & Interventional Pulmonology
  • 2015 .01  ~   :  ´ëÇаáÇÙ ¹× È£Èí±âÇÐȸ ÇмúÀ§¿ø
  • 2015 .06  ~   :  ´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ ±âħ¿¬±¸È¸ ÇмúÀ§¿ø
  • 2015 .06  ~  2015 .11  :  ´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ MERS-CoV Task Force Team ÆÀ¿ø
  • 2015 .11  ~  2018 .12  :  ´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ ÁßÁõ È£Èí±â°¨¿°º´¿¬±¸È¸ °£»ç
  • 2016 .01  ~   :  ´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ ¼ö·Ã±³À°À§¿ø
  • 2016 .01  ~   :  ´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ õ½Ä¿¬±¸È¸ ¿î¿µÀ§¿ø
  • 2016 .10  ~   :  ´ëÇѳ»°úÇÐȸ ¼ö·ÃÀ§¿ø
  • 2017 .01  ~  2017 .12  :  2018 ¸¸¼ºÆó¼â¼ºÆóÁúȯ ÀÓ»óÁø·áÁöħ ÇмúÀ§¿ø
  • 2019 .01  ~   :  ´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ °£ÇàÀ§¿ø / Áø·áÁöħÀ§¿ø / COPD ¿¬±¸È¸¿î¿µÀ§¿ø / ÁßÁõÈ£Èí±â°¨¿°º´¿¬±¸È¸ À繫À§¿ø
  • 2019 .05  ~   :  2020 õ½Ä ÀÓ»óÁø·áÁöħ °³Á¤ ¿î¿µÀ§¿ø ¹× ÇмúÀ§¿ø
  • 2019 .06  ~   :  APSR 2021 ÁغñÀ§¿øȸ ÀçÁ¤ºÐ°úÀ§¿ø
  • 2020 .01  ~   :  ´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ COPD¿¬±¸È¸ Ãѹ« / ±âħ¿¬±¸È¸ ºÎȸÀå
  • 2020 .01  ~   :  ´ëÇѳ»°úÇÐȸ À±¸®À§¿ø
  • 2020 .06  ~   :  ´ëÇÑÀÇÇÐȸ 2020 õ½Ä ÀÓ»óÁø·áÁöħ °³¹ß(ÁýÇÊ) À§¿øȸ À§¿ø

³í¹®

more
  • [SCI] (Relationship Between Particulate Matter (PM 10) and Airway Inflammation Measured With Exhaled Nitric Oxide Test in Seoul)
  • [SCI] (The association between blood eosinophil percent and bacterial infection in acute exacerbation of chronic obstructive pulmonary disease.)
  • [SCI] (Bacterial and Viral Identification Rate in Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Korea)
  • [SCI] (The Economic Effect of Early Management in Patients with Early Chronic Obstructive Pulmonary Disease: Results from a Population-Based Nationwide Survey.)
  • [SCI] (Pseudomonas aeruginosa infection increases the readmission rate of COPD patients)
  • [SCI] (Clinical Significance of Serum Vascular Endothelial Growth Factor in Young Male Asthma Patients.)
  • [±¹³»³í¹®] (Severe Endobronchial Inflammation Induced by Aspiration of a Ferrous Sulfate Tablet. [Case Report])
  • [SCI] (Serum Procalcitonin for Differential Diagnosis of Acute Exacerbation and Bacterial Pneumonia in Patients With Interstitial Lung Disease.)
  • [SCI] (Centrilobular Cysts of the Lung. [Image])
  • [±¹³»³í¹®] (A Case of IgG4-Related Disease Presenting as Massive Pleural Effusion and Thrombophlebitis[Case Report])
  • [±¹³»³í¹®] (Two Cases of Diagnosis and Removal of Endobronchial Hamartoma by Cryotherapy via Flexible Bronchoscopy[Case report])
  • [SCI] (Clinical Characteristics and Corticosteroid Treatment of Acute Eosinophilic Pneumonia.)
  • [SCI] (Clinical Characteristics and Corticosteroid Treatment of Acute Eosinophilic Pneumonia.)
  • [SCI] (Comparison between surgery and radiofrequency ablation for stage I non-small cell lung cancer.)
  • [SCI] (Coexistence of allergic bronchopulmonary aspergillosis and active pulmonary tuberculosis[Letter to the Editor])
  • [SCI] (. Clinical usefulness of D2-40 in non-small cell lung cancer.)
  • [SCI] (Right pulmonary agenesis in a 12-year-old girl)
  • [SCI] (A 38-year-old woman with bilateral cystic lesions in both lower lung lobes.)
  • [SCI] (Whole-body magnetic resonance imaging for staging metastatic thymic carcinoma)
  • [SCI] (Early-stage lung cancer mimicking pulmonary arteriovenous malformation.)
  • [SCI] (Solitary bronchial squamous papilloma presenting as a plaque-like lesion in a subject with asthma)
  • [SCI] (Treatment of asymptomatic pulmonary cryptococcosis in immunocompetent hosts with oral fluconazole.)
  • [SCI] (Late Endobronchial Metastasis from Rectal Cancer that Mimics a Primary Lung Cancer.)
  • [SCI] (An unusual localized progressive fibrotic cavity mimicking lung malignancy in idiopathic pulmonary fibrosis)
  • [SCI] (A Novel Dithiol Amide CB3 Attenuates Allergic Airway Disease through Negative Regulation of p38 MAPK. )
  • [SCI] (Coexistence of allergic bronchopulmonary aspergillosis and active pulmonary tuberculosis.)
  • [SCI] (Clinical usefulness of D2-40 in non-small cell lung cancer.)
  • [SCI] (Acute eosinophilic pneumonia associated with 2009 influenza A (H1N1).[Case report])
  • [SCI] (HIF-1¥á inhibition ameliorates an allergic airway disease via VEGF suppression in bronchial epithelium. )
  • [SCI] (Phosphoinositide 3-kinase ¥ä inhibitor suppresses interleukin-17 expression in a murine asthma model.)
  • [SCI] (Involvement of sirtuin 1 in airway inflammation and hyperresponsiveness of allergic airway disease. )
  • [SCI] (Acute eosinophilic pneumonia associated with 2009 influenza A (H1N1). )
  • [SCI] (Multidrug-resistant pulmonary tuberculosis among young Korean soldiers in a communal setting.)
  • [SCI] (Peroxisome proliferator-activated receptor gamma agonist down-regulates IL-17 expression in a murine model of allergic airway inflammation)
  • [SCI] (. Phosphoinositide 3-kinase delta inhibitor as a novel therapeutic agent in asthma [Review article])
  • (¸¸¼º Æó¼â¼º ÆóÁúȯ ±Þ¼º ¾ÇÈ­ ½Ã C-¹ÝÀÀ´Ü¹é°ú Æóµ¿¸Æ °íÇ÷¾ÐÀÇ °ü°è)
  • [SCI] (Low attenuation area is associated with airflow limitation and airway hyperresponsiveness.)
  • [SCI] (Clinical significance of plasma and serum vascular endothelial growth factor in asthma. )
  • [SCI] (Mast cells can mediate vascular permeability through regulation of the PI3K-HIF-1alpha-VEGF axis. )
  • [SCI] (Angiopoietin-1 variant, COMP-Ang1 attenuates hydrogen peroxide-induced acute lung injury.)
  • [SCI] (Inhibition of VEGF blocks TGF-beta1 production through a PI3K/Akt signalling pathway. )
  • [SCI] (Phosphoinositide 3-kinase delta inhibitor as a novel therapeutic agent in asthma.)
  • (Kartagener ÁõÈıº ȯÀÚÀÇ ±Þ¼ºÈ£ÈíºÎÀü - ºñħ½ÀÀû ȯ±âÄ¡·á·Î È£ÀüµÈ 1¿¹.)
  • [±¹³»³í¹®] (ÀÌ´ÞÀÇ X-¼± : ´Ù±â°ü ħ¹üÀ» µ¿¹ÝÇÑ °Å´ë Æó ¸ð¼¼Æ÷Á¾.)
  • [SCI] (A novel thiol compound, N-acetylcysteine amide, attenuates allergic airway disease by regulating activation of NF-kappaB and hypoxia-inducible factor-1alpha. )
  • [SCI] (Blockade of airway inflammation and hyper-responsiveness by an angiopoietin-1 variant, COMP-Ang1.)
  • [SCI] (Change of connexin 37 in allergen-induced airway inflammation. )
  • [SCI] (PTEN down-regulates IL-17 expression in a murine model of toluene diisocyanate-induced airway disease)
  • [SCI] (Cysteinyl leukotriene upregulates IL-11 expression in allergic airway disease of mice.)
  • [SCI] (Vascular endothelial growth factor modulates matrix metalloproteinase-9 expression in asthma)
  • [±¹³»³í¹®] (¸¸¼ºÆó¼â¼ºÆóÁúȯ°ú õ½ÄÀÇ °¨º°Áø´Ü¿¡¼­ ¸ÞŸÄݸ° ±â°üÁöÀ¯¹ß°Ë»çÀÇ ÀÇÀÇ)
  • [±¹³»³í¹®] (Kartagener ÁõÈıº ȯÀÚÀÇ ±Þ¼ºÈ£ÈíºÎÀü-ºñħ½ÀÀû ȯ±âÄ¡·á·Î È£ÀüµÈ 1¿¹)
  • [SCI] (Modulation of airway remodeling and airway inflammation by peroxisome proliferator-activated receptor gamma in a murine model of toluene diisocyanate-induced asthma.)
  • [SCI] (Phosphoinositide 3-kinase-delta inhibitor reduces vascular permeability in a murine model of asthma.)
  • [SCI] (Antioxidant down-regulates interleukin-18 expression in asthma.)
  • [SCI] (An antioxidant modulates expression of receptor activator of NF-kappaB in asthma.)
  • [SCI] (Peroxisome proliferator activated receptor-gamma modulates reactive oxygen species generation and activation of nuclear factor-kappaB and hypoxia-inducible factor 1alpha in allergic airway disease of mice.)
  • [SCI] (Hydrogen peroxide induces vascular permeability via regulation of vascular endothelial growth factor. )
  • [SCI] (Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) reduces vascular endothelial growth factor expression in allergen-induced airway inflammation.)
  • [SCI] (Vascular endothelial growth factor modulates matrix metalloproteinase-9 expression in asthma.)
  • [±¹³»³í¹®] (°¢±â ´Ù¸¥ ¹æ¹ýÀ¸·Î Ä¡·áÇÑ Àå°£¸· Á¤¸Æ Ç÷ÀüÁõ 3¿¹.)
  • [±¹³»³í¹®] (³»½Ã°æ Á¶Á÷ »ý°Ë ÈÄ ¹ß»ýÇÑ ±Þ¼º °Å´ë ÃâÇ÷¼º À§±Ë¾ç 1¿¹. )
  • [SCI] (Involvement of IL-10 in peroxisome proliferator-activated receptor gamma-mediated anti-inflammatory response in asthma.)
  • [SCI] (A prodrug of cysteine, L-2-oxothiazolidine-4-carboxylic acid, regulates vascular permeability by reducing vascular endothelial growth factor expression in asthma. )
  • [±¹³»³í¹®] Ç÷û ¹× ¼¼Æ÷³» ¸¶±×³×½· ³óµµ¿Í ´ç´¢º´¼º ¹Ì¼¼Ç÷°ü ÇÕº´ÁõÀÇ °ü°è.
  • [±¹³»³í¹®] (¡®°ü»óµ¿¸Æ ½ºÅÙÆ®¡¯·Î Ä¡·áÇÑ º£Ã¼Æ®º´¿¡ µ¿¹ÝµÈ ±Þ¼º ½É±Ù°æ»öÁõ 1¿¹.)
  • [±¹³»³í¹®] (°ñ¼ö¿¡¼­ ¹ß»ýÇÑ CD34, CD99¸¦ µ¿¹Ý ¹ßÇöÇÏ´Â ¿ø½Ã¼º ½Å°æ¿Ü¹è¿± Á¾¾ç)
  • [±¹³»³í¹®] (¸í¹éÇÑ ½Å ±â´É Àå¾Ö°¡ ¾ø´Â Á¦2Çü ´ç´¢º´ ȯÀÚ¿¡¼­ ¹ß»ýÇÑ ºóÇ÷ÀÇ ÀÓ»óÀû Ư¡)
  • [SCI] Ư¹ß¼º Ç÷¼ÒÆÇ °¨¼Ò¼º ÀÚ¹ÝÁõ°ú µ¿¹ÝµÈ Takayasu µ¿¸Æ¿° 1¿¹.
  • [±¹³»³í¹®] Ç÷û ¹× ¼¼Æ÷³» ¸¶±×³×½· ³óµµ¿Í ´ç´¢º´¼º ¹Ì¼¼Ç÷°ü ÇÕº´ÁõÀÇ °ü°è.
  • [±¹³»³í¹®] (´ëÀå³»½Ã°æ°Ë»ç¿¡¼­ÀÇ ¹Ì¼¼¿ëÁ¾ÀÇ ÀÓ»óÀû Ư¡.)
  • [±¹³»³í¹®] (Ç÷°üÀ°Á¾ÀÇ ÀüÀÌ·Î ÀÎÇÑ »óºÎ À§Àå°ü ÃâÇ÷ 1¿¹)

Àú¼­

more
  • °¨¿°°ü¸®Áöħ(Infection Control Guideline) 3ÆÇ
  • È£Èí±âÇÐ Manual, 1ÆÇ
  • È£Èí±âÇÐ Manual, 2ÆÇ

ÃÖÁ¾¼öÁ¤ÀÏ : 2023.03.06